It is suggested that the lower abundance in GII, a group with higher-grade neoplasms, may be related to an aberrant methylation of the KRT18 gene [79], thus causing silencing of this gene and lower expression of the protein in this group. The gene discussed is KRT18; the disease is neoplasm.